289 related articles for article (PubMed ID: 26818663)
1. E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease.
Yu Q; Zhang S; Chao K; Feng R; Wang H; Li M; Chen B; He Y; Zeng Z; Chen M
J Crohns Colitis; 2016 Jun; 10(6):713-25. PubMed ID: 26818663
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL-induced caspase activation.
Wu Y; Kimura Y; Okamoto T; Matsuhisa K; Asada R; Saito A; Sakaue F; Imaizumi K; Kaneko M
Sci Rep; 2019 Dec; 9(1):20301. PubMed ID: 31889078
[TBL] [Abstract][Full Text] [Related]
5. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
7. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis.
Geng R; Tan X; Wu J; Pan Z; Yi M; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Cell Death Dis; 2017 Aug; 8(8):e2994. PubMed ID: 28796265
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.
Nguyen HT; Dalmasso G; Müller S; Carrière J; Seibold F; Darfeuille-Michaud A
Gastroenterology; 2014 Feb; 146(2):508-19. PubMed ID: 24148619
[TBL] [Abstract][Full Text] [Related]
9. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
[TBL] [Abstract][Full Text] [Related]
10. Divergent influence of microRNA-21 deletion on murine colitis phenotypes.
Wu F; Dong F; Arendovich N; Zhang J; Huang Y; Kwon JH
Inflamm Bowel Dis; 2014 Nov; 20(11):1972-85. PubMed ID: 25222661
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-590-5p Inhibits Intestinal Inflammation by Targeting YAP.
Yu M; Luo Y; Cong Z; Mu Y; Qiu Y; Zhong M
J Crohns Colitis; 2018 Jul; 12(8):993-1004. PubMed ID: 29912317
[TBL] [Abstract][Full Text] [Related]
12. miRNA-129/FBW7/NF-κB, a Novel Regulatory Pathway in Inflammatory Bowel Disease.
Meng Q; Wu W; Pei T; Xue J; Xiao P; Sun L; Li L; Liang D
Mol Ther Nucleic Acids; 2020 Mar; 19():731-740. PubMed ID: 31945730
[TBL] [Abstract][Full Text] [Related]
13. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.
Ukil A; Maity S; Das PK
Br J Pharmacol; 2006 Sep; 149(1):121-31. PubMed ID: 16880762
[TBL] [Abstract][Full Text] [Related]
14. [Protein ubiquitination on the regulation of inflammatory bowel disease].
Ling J; Li H; Chen W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):82-88. PubMed ID: 30146816
[TBL] [Abstract][Full Text] [Related]
15. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation.
Zhou W; Cao Q; Peng Y; Zhang QJ; Castrillon DH; DePinho RA; Liu ZP
Gastroenterology; 2009 Oct; 137(4):1403-14. PubMed ID: 19560465
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.
Lee JH; Lee B; Lee HS; Bae EA; Lee H; Ahn YT; Lim KS; Huh CS; Kim DH
Int J Colorectal Dis; 2009 Feb; 24(2):231-7. PubMed ID: 19050899
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.
Visekruna A; Joeris T; Seidel D; Kroesen A; Loddenkemper C; Zeitz M; Kaufmann SH; Schmidt-Ullrich R; Steinhoff U
J Clin Invest; 2006 Dec; 116(12):3195-203. PubMed ID: 17124531
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease.
Kim HY; Kwon HY; Ha Thi HT; Lee HJ; Kim GI; Hahm KB; Hong S
J Gastroenterol Hepatol; 2016 Oct; 31(10):1727-1735. PubMed ID: 26878986
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
